Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

View all journals
Search
Log in

nature
search

Search

Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

British Journal of Cancer (10)
Scientific Reports (4)
Modern Pathology (2)
Oncogene (2)
Journal of Human Genetics (1)

Choose more journals

Article type Check one or more article types to show results from those article types only.

Research (18)
Amendments and Corrections (1)
Correspondence (1)
News & Views (1)

Subject Check one or more subjects to show results from those subjects only.

Cancer
Cell biology
Diseases
Drug discovery
Gastroenterology
Genetics
Health care
Medical research
Molecular biology
Oncology

Date Choose a date option to show results from those dates only.

Today
Last 7 days
Last 30 days
Last 12 months
Last 2 years
Last 5 years

Custom date range

Clear all filters

Sort by:

Relevance

Date published (new to old)

Date published (old to new)

Showing 1–21 of 21 results

Advanced filters: Author: Ann-Lii Cheng Clear advanced filters

Prompt initiation of durvalumab and tremelimumab for unresectable hepatocellular carcinoma in patients with chronic active hepatitis B: a phase 2 clinical trial

Yu-Yun Shao
Ching-Tso Chen
Chih-Hung Hsu
Research24 Mar 2025
British Journal of Cancer

Volume: 132, P: 822-827
5-Fluorouracil-related encephalopathy: at least two distinct pathogenetic mechanisms exist - reply

Kun-Huei Yeh
Ann-Lii Cheng
Correspondence01 May 1998
British Journal of Cancer

Volume: 77, P: 1711-1712
Bcl-2 prevents topoisomerase II inhibitor GL331-induced apoptosis is mediated by down-regulation of poly(ADP-ribose)polymerase activity

Min-Liang Kuo
Shing-Chuan Shen
Tze-Sing Huang
Research29 Oct 1998
Oncogene

Volume: 17, P: 2225-2234
Efficacy and safety of cabozantinib for patients with advanced hepatocellular carcinoma based on albumin-bilirubin grade

Robin Kate Kelley
Rebecca Miksad
Ghassan K. Abou-Alfa
ResearchOpen Access07 Oct 2021
British Journal of Cancer

Volume: 126, P: 569-575
Urine protein:creatinine ratio vs 24-hour urine protein for proteinuria management: analysis from the phase 3 REFLECT study of lenvatinib vs sorafenib in hepatocellular carcinoma

Thomas R. Jeffry Evans
Masatoshi Kudo
Max W. Sung
ResearchOpen Access28 Jun 2019
British Journal of Cancer

Volume: 121, P: 218-221
TP53 Mutational Analysis Enhances the Prognostic Accuracy of IHC4 and PAM50 Assays

Ching-Hung Lin
I-Chiun Chen
Ann-Lii Cheng
ResearchOpen Access16 Dec 2015
Scientific Reports

Volume: 5, P: 1-9
Pursuing efficacious systemic therapy for hepatocellular carcinoma

In 2020, combination treatments have pushed the efficacy of systemic therapy for hepatocellular carcinoma (HCC) to an unprecedented high, providing a solid base for the future pursuit of further improved, highly efficacious systemic therapies for HCC.

Ann-Lii Cheng
News & Views06 Jan 2021
Nature Reviews Gastroenterology & Hepatology

Volume: 18, P: 95-96
Two first-in-human studies of xentuzumab, a humanised insulin-like growth factor (IGF)-neutralising antibody, in patients with advanced solid tumours

Johann de Bono
Chia-Chi Lin
Ann-Lii Cheng
ResearchOpen Access12 Mar 2020
British Journal of Cancer

Volume: 122, P: 1324-1332
Selective inhibition of HDAC6 promotes bladder cancer radiosensitization and mitigates the radiation-induced CXCL1 signalling

Yu-Chieh Tsai
Tzu-Yin Wang
Sheng-Fang Su
ResearchOpen Access21 Feb 2023
British Journal of Cancer

Volume: 128, P: 1753-1764
Correction: Urine protein:creatinine ratio vs 24-hour urine protein for proteinuria management: analysis from the phase 3 REFLECT study of lenvatinib vs sorafenib in hepatocellular carcinoma

Thomas R. Jeffry Evans
Masatoshi Kudo
Max W. Sung
Amendments and CorrectionsOpen Access30 Jul 2019
British Journal of Cancer

Volume: 121, P: 625
Phosphorylation of p53 on Thr55 by ERK2 is necessary for doxorubicin-induced p53 activation and cell death

Pei Yen Yeh
Shuang-En Chuang
Ann-Lii Cheng
Research29 Apr 2004
Oncogene

Volume: 23, P: 3580-3588
Low miR-10b-3p associated with sorafenib resistance in hepatocellular carcinoma

Yu-Yun Shao
Pai-Sheng Chen
Da-Liang Ou
Research02 Mar 2022
British Journal of Cancer

Volume: 126, P: 1806-1814
First-line antibiotic therapy in Helicobacter pylori-negative low-grade gastric mucosa-associated lymphoid tissue lymphoma

Sung-Hsin Kuo
Kun-Huei Yeh
Ann-Lii Cheng
ResearchOpen Access30 Oct 2017
Scientific Reports

Volume: 7, P: 1-13
Novel prognostic implications of complement activation in the tumour microenvironment for de novo metastatic BRAF V600E mutant colorectal cancer

Kuo-Hsing Chen
Chia-Lang Hsu
Kun-Huei Yeh
Research01 Nov 2022
British Journal of Cancer

Volume: 128, P: 102-111
Association between risk factors, molecular features and CpG island methylator phenotype colorectal cancer among different age groups in a Taiwanese cohort

Kuo-Hsing Chen
Liang-In Lin
Kun-Huei Yeh
Research12 Apr 2021
British Journal of Cancer

Volume: 125, P: 48-54
High prevalence of APOA1/C3/A4/A5 alterations in luminal breast cancers among young women in East Asia

Ching-Hung Lin
Ruby Yun-Ju Huang
Ann-Lii Cheng
ResearchOpen Access05 Jul 2021
npj Breast Cancer

Volume: 7, P: 1-10
Phosphatidylinositol-3 Kinase Inhibitors, Buparlisib and Alpelisib, Sensitize Estrogen Receptor-positive Breast Cancer Cells to Tamoxifen

I-Chun Chen
Li-Ping Hsiao
Yen-Shen Lu
ResearchOpen Access29 Aug 2017
Scientific Reports

Volume: 7, P: 1-10
Clinical Relevance of Liver Kinase B1(LKB1) Protein and Gene Expression in Breast Cancer

I-Chun Chen
Yuan-Ching Chang
Ann-Lii Cheng
ResearchOpen Access15 Feb 2016
Scientific Reports

Volume: 6, P: 1-10
Multimodel assessment of BRCA1 mutations in Taiwanese (ethnic Chinese) women with early-onset, bilateral or familial breast cancer

Wen-Hong Kuo
Po-Han Lin
King-Jen Chang
Research26 Jan 2012
Journal of Human Genetics

Volume: 57, P: 130-138
Inhibition of ZEB1 by miR-200 characterizes Helicobacter pylori-positive gastric diffuse large B-cell lymphoma with a less aggressive behavior

Wei-Ting Huang
Sung-Hsin Kuo
Chung-Wu Lin
Research03 Jan 2014
Modern Pathology

Volume: 27, P: 1116-1125
E2A-positive gastric MALT lymphoma has weaker plasmacytoid infiltrates and stronger expression of the memory B-cell-associated miR-223: possible correlation with stage and treatment response

Ting-Yun Liu
Shee-Uan Chen
Chung-Wu Lin
Research27 Aug 2010
Modern Pathology

Volume: 23, P: 1507-1517

Search

Search articles by subject, keyword or author

Show results from

Advanced search

Quick links

Explore articles by subject
Find a job
Guide to authors
Editorial policies

Nature.com

nature.com sitemap

About Nature Portfolio

About us
Press releases
Press office
Contact us

Discover content

Journals A-Z
Articles by subject
protocols.io
Nature Index

Publishing policies

Nature portfolio policies
Open access

Author & Researcher services

Reprints & permissions
Research data
Language editing
Scientific editing
Nature Masterclasses
Research Solutions

Libraries & institutions

Librarian service & tools
Librarian portal
Open research
Recommend to library

Advertising & partnerships

Advertising
Partnerships & Services
Media kits
Branded content

Professional development

Nature Awards
Nature Careers
Nature Conferences

Regional websites

Nature Africa
Nature China
Nature India
Nature Japan
Nature Middle East

Privacy Policy
Use of cookies
Legal notice
Accessibility statement
Terms & Conditions
Your US state privacy rights

Search

Prompt initiation of durvalumab and tremelimumab for unresectable hepatocellular carcinoma in patients with chronic active hepatitis B: a phase 2 clinical trial

5-Fluorouracil-related encephalopathy: at least two distinct pathogenetic mechanisms exist - reply

Bcl-2 prevents topoisomerase II inhibitor GL331-induced apoptosis is mediated by down-regulation of poly(ADP-ribose)polymerase activity

Efficacy and safety of cabozantinib for patients with advanced hepatocellular carcinoma based on albumin-bilirubin grade

Urine protein:creatinine ratio vs 24-hour urine protein for proteinuria management: analysis from the phase 3 REFLECT study of lenvatinib vs sorafenib in hepatocellular carcinoma

TP53 Mutational Analysis Enhances the Prognostic Accuracy of IHC4 and PAM50 Assays

Pursuing efficacious systemic therapy for hepatocellular carcinoma

Two first-in-human studies of xentuzumab, a humanised insulin-like growth factor (IGF)-neutralising antibody, in patients with advanced solid tumours

Selective inhibition of HDAC6 promotes bladder cancer radiosensitization and mitigates the radiation-induced CXCL1 signalling

Correction: Urine protein:creatinine ratio vs 24-hour urine protein for proteinuria management: analysis from the phase 3 REFLECT study of lenvatinib vs sorafenib in hepatocellular carcinoma

Phosphorylation of p53 on Thr55 by ERK2 is necessary for doxorubicin-induced p53 activation and cell death

Low miR-10b-3p associated with sorafenib resistance in hepatocellular carcinoma

First-line antibiotic therapy in Helicobacter pylori-negative low-grade gastric mucosa-associated lymphoid tissue lymphoma

Novel prognostic implications of complement activation in the tumour microenvironment for de novo metastatic BRAF V600E mutant colorectal cancer

Association between risk factors, molecular features and CpG island methylator phenotype colorectal cancer among different age groups in a Taiwanese cohort

High prevalence of APOA1/C3/A4/A5 alterations in luminal breast cancers among young women in East Asia

Phosphatidylinositol-3 Kinase Inhibitors, Buparlisib and Alpelisib, Sensitize Estrogen Receptor-positive Breast Cancer Cells to Tamoxifen

Clinical Relevance of Liver Kinase B1(LKB1) Protein and Gene Expression in Breast Cancer

Multimodel assessment of BRCA1 mutations in Taiwanese (ethnic Chinese) women with early-onset, bilateral or familial breast cancer

Inhibition of ZEB1 by miR-200 characterizes Helicobacter pylori-positive gastric diffuse large B-cell lymphoma with a less aggressive behavior

E2A-positive gastric MALT lymphoma has weaker plasmacytoid infiltrates and stronger expression of the memory B-cell-associated miR-223: possible correlation with stage and treatment response

Search

Quick links